TANDEM DIABETES CARE, INC.
Item 8.01 Other Events.
On November 3, 2023, the U.S. Food and Drug Administration (FDA) cleared our 510(k) applications for our t:slim X2 insulin pump and enhancements to our Control-IQ technology with expanded pediatric indications for use in individuals two years of age and older.
2
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Tandem Diabetes Care Inc. published this content on 06 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 November 2023 11:04:51 UTC.
